Table 1.
Overview of measurements per time point
| Outcomes patients | Instrument | Short term | T0 | T1 | T2 | T3* | T4* |
|---|---|---|---|---|---|---|---|
| Demographic and clinical characteristics | - | - | X | - | - | - | - |
| Self-efficacy | Epilepsy Self-efficacy Scale – 33 items | ESES | X | X | X | X | X |
| General self-efficacy | Generic Self-efficacy Scale – 10 items | GSES | X | X | X | X | X |
| Adherence | MEMS Medication Adherence Scale | MARS 5 | X | X | X | X | X |
| Seizure frequency | Questionnaire seizure frequency | - | X | X | X | X | X |
| Seizure severity | National Hospital Seizure Severity Scale | NHS3 | X | X | X | X | X |
| Emotional functioning | Hospital Anxiety and Depression Scale | HADS | X | X | X | X | X |
| Quality of life | Quality Of Life in Epilepsy | QOLIE31P | X | X | X | X | X |
| Generic quality of life | EQ-5D-5L | X | X | X | X | X | |
| Proactive coping | Utrecht Proactive Coping Competence | UPCC/PCI | X | X | X | X | X |
| Side effect | Side effects of Anti-epileptic Drugs | SIDAED | X | X | X | X | X |
| Healthcare resource use | Medical Cost Questionnaire | MCQ | X | X | X | X | X |
| Productivity Cost Questionnaire | PCQ |
T0 = baseline outcome assessments; T1 = Outcome assessments after 3 months; T2 = Outcome assessments after 6 months; T3 = Outcome assessments after 9 months; T4 = Outcome assessments after 12 months.
*Outcome assessment applicable only for intervention group.